Predicting and preventing autoimmunity: the case of anti-mitochondrial antibodies

Auto Immun Highlights. 2012 Oct 16;3(3):105-12. doi: 10.1007/s13317-012-0038-z. eCollection 2012 Dec.

Abstract

To be able to predict who will develop autoimmune disease would allow for early treatment which may dramatically alter the course of the disease. In some cases, it may also lead to prevention of the disease development. The prediction of disease development is based on the analysis of risk factors which have been associated with the disease in question. These factors include genetic susceptibility, as well as immunological and environmental factors. One autoimmune disease that may serve as a model for disease prediction is primary biliary cirrhosis (PBC), an autoimmune liver disease affecting the small- and medium-sized bile ducts. PBC could be an ideal model due to recent advances in elucidating its genetic associations. As well, a variety of immunological and environmental risk factors have been well established. Indeed, the presence of PBC-specific antimitochondrial antibodies and/or antinuclear antibodies has been shown to be predictor of disease development and possibly prognosis. This review will examine the current evidence which suggests that we may potentially be able to predict the development of PBC in some individuals. These concepts may also be applied to autoimmune diseases in general.

Keywords: Autoimmune disease; Autoimmunity; Genetics; Prediction; Prevention; Risk factor; Susceptibility.

Publication types

  • Review